Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fabrinet (FN) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Fabrinet vs Vir Biotechnology Inc. Common Stock — how do they compare? Fabrinet trades at $384 (market cap $15.33B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Fabrinet is far larger — about 8.5× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Fabrinet nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fabrinet for 31 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

FNVIR
Market Cap
$15.33B$1.80B
Volume
1,120,1871,782,836
Sector
TechnologyHealth
52-Week High
$746.47$11.78
52-Week Low
$374.91$5.12
Typical Hold Time
31 Days0 Days
Enterprise Value
$14.46B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fabrinet

Fabrinet (FN) trades at $427.82, down 6.26% in the last session amid broader market volatility. The stock shows strong fundamental performance with three consecutive quarterly earnings beats and robust 45% revenue growth in Q4 2026. Technical indicators present a mixed picture with a bullish overall signal but bearish moving averages, while support levels cluster around $407-$441. The company benefits from surging AI data center demand and capacity expansion initiatives.

Fabrinet's outlook remains positive driven by AI infrastructure growth, though risks include customer concentration and margin pressure. Analysts project 64% upside to the $769.50 consensus target with unanimous bullish sentiment (18 buys, 0 sells). The stock offers exposure to high-growth optical manufacturing but faces execution risks in capital expansion.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FN
56% Buy44% Sell
Avg holding period · 31 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Fabrinet

Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.

Read more on FN →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →